Home › Funds › MFS Investment Management › REGN

MFS Investment Management position in REGN

REGENERON PHARMACEUTICALS · Health Care

Latest position (Q2 2025)20.20K sh
Reported value held$10.61M
Portfolio Weight0.00%
First reportedQ2 2021
Last changeReduce

Quarter by quarter

QuarterSharesValueChange
Q2 2021 2.65K $1.48M New
Q3 2022 198.41K $136.68M New
Q4 2022 548.27K $395.57M Add
Q1 2023 551.53K $453.17M Add
Q2 2023 550.72K $395.72M Hold
Q3 2023 235.47K $193.78M Reduce
Q4 2023 242.35K $212.85M Add
Q1 2024 480.52K $462.50M Add
Q2 2024 540.29K $567.86M Add
Q3 2024 514.26K $540.62M Reduce
Q4 2024 15.23K $10.85M Reduce
Q1 2025 20.96K $13.30M Add
Q2 2025 20.20K $10.61M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

Other funds holding REGN

All REGN fund holders →